The present study thus demonstrates that the RGS4 inhibition is the promising strategy for the treatment of noise-induced cochlear injury and introduces a novel paradigm for the treatment of NIHL and other forms of SNHL based on regulation of GPCR. This evidence concerns the gene RGS4 and noise induced hearing loss.